[Federal Register Volume 61, Number 195 (Monday, October 7, 1996)]
[Rules and Regulations]
[Page 52287]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25665]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Parts 1309, 1310, 1313
[DEA NUMBER 138P]
RIN 1117-AA32
Removal of Exemption for Certain Pseudoephedrine Products
Marketed Under the Food, Drug, and Cosmetic Act (FD&C Act)
AGENCY: Drug Enforcement Administration (DEA), Justice.
ACTION: Final rule; withdrawal.
-----------------------------------------------------------------------
SUMMARY: DEA is withdrawing its rulemaking regarding Removal of
Exemption for Certain Pseudoephedrine Products Marketed Under the Food,
Drug, and Cosmetic Act (FD&C Act) which was published in the Federal
Register on August 7, 1996 (61 FR 40981). The final rule has been
superseded by the Comprehensive Methamphetamine Control Act of 1996,
which declares the final rule null and void and of no effect.
FOR FURTHER INFORMATION CONTACT: Frank Sapienza, Chief, Drug and
Chemical Evaluation Section, Office of Diversion Control, Drug
Enforcement Administration, Washington, DC. 20537, Telephone (202) 307-
7183.
SUPPLEMENTARY INFORMATION: DEA published a notice of proposed
rulemaking (NPRM) regarding Removal of Exemption for Certain
Pseudoephedrine Products Marketed Under the Food, Drug, and Cosmetic
Act (FD&C Act) in the Federal Register on October 31, 1995 (60 FR
55348). The NPRM proposed certain amendments to Title 21, Code of
Federal Regulations (CFR), Parts 1309, 1310, and 1313, and was open for
public comment until January 2, 1996. Following the comment period, DEA
published a final rulemaking on August 7, 1996 (61 FR 40981), which was
to become effective on October 7, 1996. However, on September 29, 1996,
Congress passed the Comprehensive Methamphetamine Control Act of 1996,
which provides that ``The final rule concerning removal of exemption
for certain pseudoephedrine products marketed under the Federal Food,
Drug, and Cosmetic Act published in the Federal Register of August 7,
1996 (61 FR 40981-40933) is null and void and of no force or effect.''
As a result, the amendments contained in the final rule are canceled
and the regulatory text of 21 CFR Parts 1309, 1310, and 1313 remains
unchanged.
Accordingly, DEA's rulemaking entitled Removal of Exemption for
Certain Pseudoephedrine Products Marketed Under the Food, Drug, and
Cosmetic Act (FD&C Act), published in the Federal Register as a
proposed rule on October 31, 1995 (60 FR 55348) and as a final rule on
August 7, 1996 (61 FR 40981), is withdrawn.
Dated: October 2, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. 96-25665 Filed 10-4-96; 8:45 am]
BILLING CODE 4410-09-M